Kewaunee Scientific Income from Continuous Operations 2010-2025 | KEQU

Kewaunee Scientific income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Kewaunee Scientific Annual Income from Continuous Operations
(Millions of US $)
2025 $12
2024 $19
2023 $1
2022 $-6
2021 $-4
2020 $-5
2019 $2
2018 $5
2017 $5
2016 $4
2015 $4
2014 $4
2013 $4
2012 $2
2011 $2
2010 $4
2009 $5
Kewaunee Scientific Quarterly Income from Continuous Operations
(Millions of US $)
2025-04-30 $5
2025-01-31 $1
2024-10-31 $3
2024-07-31 $2
2024-04-30 $11
2024-01-31 $3
2023-10-31 $3
2023-07-31 $3
2023-04-30 $1
2023-01-31 $1
2022-10-31 $0
2022-07-31 $-1
2022-04-30 $0
2022-01-31 $-1
2021-10-31 $-3
2021-07-31 $-1
2021-04-30 $-3
2021-01-31 $0
2020-10-31 $0
2020-07-31 $-1
2020-04-30 $-1
2020-01-31 $-2
2019-10-31 $-2
2019-07-31 $0
2019-04-30 $-1
2019-01-31 $0
2018-10-31 $1
2018-07-31 $1
2018-04-30 $2
2018-01-31 $1
2017-10-31 $2
2017-07-31 $1
2017-04-30 $1
2017-01-31 $0
2016-10-31 $2
2016-07-31 $1
2016-04-30 $1
2016-01-31 $1
2015-10-31 $1
2015-07-31 $1
2015-04-30 $1
2015-01-31 $1
2014-10-31 $1
2014-07-31 $1
2014-04-30 $1
2014-01-31 $1
2013-10-31 $1
2013-07-31 $2
2013-04-30 $1
2013-01-31 $1
2012-10-31 $1
2012-07-31 $1
2012-04-30 $2
2012-01-31 $0
2011-10-31 $0
2011-07-31 $0
2011-04-30 $0
2011-01-31 $0
2010-10-31 $1
2010-07-31 $1
2010-04-30 $0
2010-01-31 $1
2009-10-31 $1
2009-07-31 $1
2009-04-30 $1
2009-01-31 $1
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.167B $0.240B
Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters and domestic manufacturing facilities are located in Statesville, North Carolina. The Company also has subsidiaries in Singapore and Bangalore, India that serve the Asian markets.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $6.393B 17.95
Harvard Bioscience (HBIO) United States $0.020B 0.00